Supratentorial glioblastoma multiforme: The role of surgical resection versus biopsy among older patients

Kaisorn L. Chaichana, Tomas Garzon-Muvdi, Scott Parker, Jon D. Weingart, Alessandro Olivi, Richard Bennett, Henry Brem, Alfredo Quinones-Hinojosa

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Background: The peak incidence of glioblastoma multiforme (GBM) occurs in those aged 65 years and older. However, studies on this patient group remain limited. The goal of this study is to evaluate the efficacy of surgery versus biopsy for older patients with these lesions. Methods: 133 and 72 consecutive patients aged 65 years and older who underwent surgery and needle biopsy for intracranial primary (de novo) GBM between 1997 and 2007 were retrospectively reviewed. Among these patients, 40 who underwent surgical resection were matched with 40 who underwent needle biopsy alone for factors consistently shown to be associated with survival [age, Karnofsky Performance Scale (KPS) indexing, eloquent involvement, radiation, temozolomide]. Survival was expressed as estimated Kaplan-Meier plots, and log-rank analysis was used to compare survival curves. Results: Mean ± standard deviation age was 73 ± 5 years, and median survival was 4.9 months. There were no significant differences in perioperative outcomes among patients who underwent surgical resection versus needle biopsy. Patients who underwent resection had median survival of 5.7 months as compared with 4.0 months for patients who underwent needle biopsy (P = 0.02). Likewise, for patients aged 70 years and older, median survival was 4.5 months for 26 patients who underwent surgical resection as compared with 3.0 months for 26 patients who underwent needle biopsy (P = 0.03). Conclusion: This study demonstrates that older patients tolerate aggressive surgery without increased surgery-related morbidity and have prolonged survival as compared with similar patients undergoing needle biopsy. These findings may help guide treatment decisions for patients, their families, and their physicians.

Original languageEnglish (US)
Pages (from-to)239-245
Number of pages7
JournalAnnals of Surgical Oncology
Volume18
Issue number1
DOIs
StatePublished - Jan 2011
Externally publishedYes

Fingerprint

Glioblastoma
Biopsy
Needle Biopsy
Survival
temozolomide
Karnofsky Performance Status
Family Physicians
Radiation

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Supratentorial glioblastoma multiforme : The role of surgical resection versus biopsy among older patients. / Chaichana, Kaisorn L.; Garzon-Muvdi, Tomas; Parker, Scott; Weingart, Jon D.; Olivi, Alessandro; Bennett, Richard; Brem, Henry; Quinones-Hinojosa, Alfredo.

In: Annals of Surgical Oncology, Vol. 18, No. 1, 01.2011, p. 239-245.

Research output: Contribution to journalArticle

Chaichana, Kaisorn L. ; Garzon-Muvdi, Tomas ; Parker, Scott ; Weingart, Jon D. ; Olivi, Alessandro ; Bennett, Richard ; Brem, Henry ; Quinones-Hinojosa, Alfredo. / Supratentorial glioblastoma multiforme : The role of surgical resection versus biopsy among older patients. In: Annals of Surgical Oncology. 2011 ; Vol. 18, No. 1. pp. 239-245.
@article{8401884c0f6c4315a737e36d692a6551,
title = "Supratentorial glioblastoma multiforme: The role of surgical resection versus biopsy among older patients",
abstract = "Background: The peak incidence of glioblastoma multiforme (GBM) occurs in those aged 65 years and older. However, studies on this patient group remain limited. The goal of this study is to evaluate the efficacy of surgery versus biopsy for older patients with these lesions. Methods: 133 and 72 consecutive patients aged 65 years and older who underwent surgery and needle biopsy for intracranial primary (de novo) GBM between 1997 and 2007 were retrospectively reviewed. Among these patients, 40 who underwent surgical resection were matched with 40 who underwent needle biopsy alone for factors consistently shown to be associated with survival [age, Karnofsky Performance Scale (KPS) indexing, eloquent involvement, radiation, temozolomide]. Survival was expressed as estimated Kaplan-Meier plots, and log-rank analysis was used to compare survival curves. Results: Mean ± standard deviation age was 73 ± 5 years, and median survival was 4.9 months. There were no significant differences in perioperative outcomes among patients who underwent surgical resection versus needle biopsy. Patients who underwent resection had median survival of 5.7 months as compared with 4.0 months for patients who underwent needle biopsy (P = 0.02). Likewise, for patients aged 70 years and older, median survival was 4.5 months for 26 patients who underwent surgical resection as compared with 3.0 months for 26 patients who underwent needle biopsy (P = 0.03). Conclusion: This study demonstrates that older patients tolerate aggressive surgery without increased surgery-related morbidity and have prolonged survival as compared with similar patients undergoing needle biopsy. These findings may help guide treatment decisions for patients, their families, and their physicians.",
author = "Chaichana, {Kaisorn L.} and Tomas Garzon-Muvdi and Scott Parker and Weingart, {Jon D.} and Alessandro Olivi and Richard Bennett and Henry Brem and Alfredo Quinones-Hinojosa",
year = "2011",
month = "1",
doi = "10.1245/s10434-010-1242-6",
language = "English (US)",
volume = "18",
pages = "239--245",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Supratentorial glioblastoma multiforme

T2 - The role of surgical resection versus biopsy among older patients

AU - Chaichana, Kaisorn L.

AU - Garzon-Muvdi, Tomas

AU - Parker, Scott

AU - Weingart, Jon D.

AU - Olivi, Alessandro

AU - Bennett, Richard

AU - Brem, Henry

AU - Quinones-Hinojosa, Alfredo

PY - 2011/1

Y1 - 2011/1

N2 - Background: The peak incidence of glioblastoma multiforme (GBM) occurs in those aged 65 years and older. However, studies on this patient group remain limited. The goal of this study is to evaluate the efficacy of surgery versus biopsy for older patients with these lesions. Methods: 133 and 72 consecutive patients aged 65 years and older who underwent surgery and needle biopsy for intracranial primary (de novo) GBM between 1997 and 2007 were retrospectively reviewed. Among these patients, 40 who underwent surgical resection were matched with 40 who underwent needle biopsy alone for factors consistently shown to be associated with survival [age, Karnofsky Performance Scale (KPS) indexing, eloquent involvement, radiation, temozolomide]. Survival was expressed as estimated Kaplan-Meier plots, and log-rank analysis was used to compare survival curves. Results: Mean ± standard deviation age was 73 ± 5 years, and median survival was 4.9 months. There were no significant differences in perioperative outcomes among patients who underwent surgical resection versus needle biopsy. Patients who underwent resection had median survival of 5.7 months as compared with 4.0 months for patients who underwent needle biopsy (P = 0.02). Likewise, for patients aged 70 years and older, median survival was 4.5 months for 26 patients who underwent surgical resection as compared with 3.0 months for 26 patients who underwent needle biopsy (P = 0.03). Conclusion: This study demonstrates that older patients tolerate aggressive surgery without increased surgery-related morbidity and have prolonged survival as compared with similar patients undergoing needle biopsy. These findings may help guide treatment decisions for patients, their families, and their physicians.

AB - Background: The peak incidence of glioblastoma multiforme (GBM) occurs in those aged 65 years and older. However, studies on this patient group remain limited. The goal of this study is to evaluate the efficacy of surgery versus biopsy for older patients with these lesions. Methods: 133 and 72 consecutive patients aged 65 years and older who underwent surgery and needle biopsy for intracranial primary (de novo) GBM between 1997 and 2007 were retrospectively reviewed. Among these patients, 40 who underwent surgical resection were matched with 40 who underwent needle biopsy alone for factors consistently shown to be associated with survival [age, Karnofsky Performance Scale (KPS) indexing, eloquent involvement, radiation, temozolomide]. Survival was expressed as estimated Kaplan-Meier plots, and log-rank analysis was used to compare survival curves. Results: Mean ± standard deviation age was 73 ± 5 years, and median survival was 4.9 months. There were no significant differences in perioperative outcomes among patients who underwent surgical resection versus needle biopsy. Patients who underwent resection had median survival of 5.7 months as compared with 4.0 months for patients who underwent needle biopsy (P = 0.02). Likewise, for patients aged 70 years and older, median survival was 4.5 months for 26 patients who underwent surgical resection as compared with 3.0 months for 26 patients who underwent needle biopsy (P = 0.03). Conclusion: This study demonstrates that older patients tolerate aggressive surgery without increased surgery-related morbidity and have prolonged survival as compared with similar patients undergoing needle biopsy. These findings may help guide treatment decisions for patients, their families, and their physicians.

UR - http://www.scopus.com/inward/record.url?scp=78651357431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651357431&partnerID=8YFLogxK

U2 - 10.1245/s10434-010-1242-6

DO - 10.1245/s10434-010-1242-6

M3 - Article

C2 - 20697823

AN - SCOPUS:78651357431

VL - 18

SP - 239

EP - 245

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 1

ER -